Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.

Plasterer C, Tsaih SW, Peck AR, Chervoneva I, O'Meara C, Sun Y, Lemke A, Murphy D, Smith J, Ran S, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Bergom C, Joshi A, Auer P, Prokop J, Rui H, Flister MJ.

Breast Cancer Res Treat. 2019 Aug;177(1):77-91. doi: 10.1007/s10549-019-05307-8. Epub 2019 Jun 4.

PMID:
31165373
2.

PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B.

Raj-Kumar PK, Liu J, Hooke JA, Kovatich AJ, Kvecher L, Shriver CD, Hu H.

Sci Rep. 2019 May 28;9(1):7956. doi: 10.1038/s41598-019-44339-4.

3.

Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.

Tran TH, Utama FE, Sato T, Peck AR, Langenheim JF, Udhane SS, Sun Y, Liu C, Girondo MA, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Palazzo JP, Bibbo M, Auer PW, Flister MJ, Hyslop T, Mitchell EP, Chervoneva I, Rui H.

Clin Cancer Res. 2018 Dec 15;24(24):6355-6366. doi: 10.1158/1078-0432.CCR-17-3280. Epub 2018 Aug 10.

PMID:
30097435
4.

Comparative Survival Analysis of Invasive Breast Cancer Patients Treated by a U.S. Military Medical Center and Matched Patients From the U.S. General Population.

Ru Y, Liu J, Fantacone-Campbell JL, Zhu K, Kovatich AJ, Hooke JA, Kvecher L, Deyarmin B, Kovatich AW, Cammarata F, Hueman MT, Rui H, Mural RJ, Shriver CD, Hu H.

Mil Med. 2017 Nov;182(11):e1851-e1858. doi: 10.7205/MILMED-D-17-00097.

PMID:
29087852
5.

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.

Peck AR, Girondo MA, Liu C, Kovatich AJ, Hooke JA, Shriver CD, Hu H, Mitchell EP, Freydin B, Hyslop T, Chervoneva I, Rui H.

Mod Pathol. 2016 Oct;29(10):1143-54. doi: 10.1038/modpathol.2016.112. Epub 2016 Jun 17.

6.

Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis.

Ellsworth RE, Toro AL, Blackburn HL, Decewicz A, Deyarmin B, Mamula KA, Costantino NS, Hooke JA, Shriver CD, Ellsworth DL.

Cancer Growth Metastasis. 2015 Jul 20;8:15-24. doi: 10.4137/CGM.S29490. eCollection 2015.

7.

Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study.

Chen Y, Bekhash A, Kovatich AJ, Hooke JA, Liu J, Kvecher L, Fantacone-Campbell JL, Mitchell EP, Rui H, Mural RJ, Shriver CD, Hu H.

PLoS One. 2015 Jun 22;10(6):e0129500. doi: 10.1371/journal.pone.0129500. eCollection 2015.

8.

Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.

Goodman CR, Sato T, Peck AR, Girondo MA, Yang N, Liu C, Yanac AF, Kovatich AJ, Hooke JA, Shriver CD, Mitchell EP, Hyslop T, Rui H.

Oncogene. 2016 Mar 17;35(11):1373-85. doi: 10.1038/onc.2015.193. Epub 2015 Jun 22.

9.

Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.

Yang N, Liu C, Peck AR, Girondo MA, Yanac AF, Tran TH, Utama FE, Tanaka T, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Rui H.

Breast Cancer Res. 2013;15(5):R73.

10.

Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.

Sato T, Tran TH, Peck AR, Girondo MA, Liu C, Goodman CR, Neilson LM, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Fuchs SY, Rui H.

Oncogene. 2014 Apr 24;33(17):2215-24. doi: 10.1038/onc.2013.172. Epub 2013 May 27.

11.

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.

Peck AR, Witkiewicz AK, Liu C, Klimowicz AC, Stringer GA, Pequignot E, Freydin B, Yang N, Ertel A, Tran TH, Girondo MA, Rosenberg AL, Hooke JA, Kovatich AJ, Shriver CD, Rimm DL, Magliocco AM, Hyslop T, Rui H.

Breast Cancer Res. 2012 Oct 4;14(5):R130. doi: 10.1186/bcr3328.

12.

Differential gene expression in primary breast tumors associated with lymph node metastasis.

Ellsworth RE, Field LA, Love B, Kane JL, Hooke JA, Shriver CD.

Int J Breast Cancer. 2011;2011:142763. doi: 10.4061/2011/142763. Epub 2011 May 15.

13.

DW4TR: A Data Warehouse for Translational Research.

Hu H, Correll M, Kvecher L, Osmond M, Clark J, Bekhash A, Schwab G, Gao D, Gao J, Kubatin V, Shriver CD, Hooke JA, Maxwell LG, Kovatich AJ, Sheldon JG, Liebman MN, Mural RJ.

J Biomed Inform. 2011 Dec;44(6):1004-19. doi: 10.1016/j.jbi.2011.08.003. Epub 2011 Aug 22.

14.

Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women.

Field LA, Love B, Deyarmin B, Hooke JA, Shriver CD, Ellsworth RE.

Cancer. 2012 Mar 1;118(5):1334-44. doi: 10.1002/cncr.26405. Epub 2011 Jul 28.

15.

Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

Peck AR, Witkiewicz AK, Liu C, Stringer GA, Klimowicz AC, Pequignot E, Freydin B, Tran TH, Yang N, Rosenberg AL, Hooke JA, Kovatich AJ, Nevalainen MT, Shriver CD, Hyslop T, Sauter G, Rimm DL, Magliocco AM, Rui H.

J Clin Oncol. 2011 Jun 20;29(18):2448-58. doi: 10.1200/JCO.2010.30.3552. Epub 2011 May 16.

16.

Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues.

Bateman NW, Sun M, Bhargava R, Hood BL, Darfler MM, Kovatich AJ, Hooke JA, Krizman DB, Conrads TP.

J Proteome Res. 2011 Mar 4;10(3):1323-32. doi: 10.1021/pr101073s. Epub 2011 Jan 19.

PMID:
21155598
17.

Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.

Ellsworth RE, Ellsworth DL, Weyandt JD, Fantacone-Campbell JL, Deyarmin B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2010 Jun;17(6):1688-94. doi: 10.1245/s10434-010-0910-x. Epub 2010 Jan 27.

PMID:
20107913
18.

Genomic instability in the breast microenvironment? A critical evaluation of the evidence.

Holliday C, Rummel S, Hooke JA, Shriver CD, Ellsworth DL, Ellsworth RE.

Expert Rev Mol Diagn. 2009 Oct;9(7):667-78. doi: 10.1586/erm.09.55. Review.

PMID:
19817552
19.

Molecular changes in primary breast tumors and the Nottingham Histologic Score.

Ellsworth RE, Hooke JA, Love B, Ellsworth DL, Shriver CD.

Pathol Oncol Res. 2009 Dec;15(4):541-7. doi: 10.1007/s12253-009-9151-3. Epub 2009 Feb 5.

PMID:
19194786
20.

Genomic heterogeneity of breast tumor pathogenesis.

Ellsworth RE, Hooke JA, Shriver CD, Ellsworth DL.

Clin Med Oncol. 2009 Jul 29;3:77-85.

21.

A gene expression signature that defines breast cancer metastases.

Ellsworth RE, Seebach J, Field LA, Heckman C, Kane J, Hooke JA, Love B, Shriver CD.

Clin Exp Metastasis. 2009;26(3):205-13. doi: 10.1007/s10585-008-9232-9. Epub 2008 Dec 27.

PMID:
19112599
22.

Environmental chemicals and breast cancer risk--a structural chemistry perspective.

Weyandt J, Ellsworth RE, Hooke JA, Shriver CD, Ellsworth DL.

Curr Med Chem. 2008;15(26):2680-701. Review.

PMID:
18991630
23.

Amplification of HER2 is a marker for global genomic instability.

Ellsworth RE, Ellsworth DL, Patney HL, Deyarmin B, Love B, Hooke JA, Shriver CD.

BMC Cancer. 2008 Oct 14;8:297. doi: 10.1186/1471-2407-8-297.

24.

Chromosomal alterations associated with the transition from in situ to invasive breast cancer.

Ellsworth RE, Vertrees A, Love B, Hooke JA, Ellsworth DL, Shriver CD.

Ann Surg Oncol. 2008 Sep;15(9):2519-25. doi: 10.1245/s10434-008-0051-7. Epub 2008 Jul 12.

PMID:
18622645
25.

Genomic alterations associated with early stages of breast tumor metastasis.

Ellsworth RE, Ellsworth DL, Patney HL, Deyarmin B, Hooke JA, Love B, Shriver CD.

Ann Surg Oncol. 2008 Jul;15(7):1989-95. doi: 10.1245/s10434-008-9902-5. Epub 2008 Apr 10.

PMID:
18401664
26.

The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.

Becker TE, Ellsworth RE, Deyarmin B, Patney HL, Jordan RM, Hooke JA, Shriver CD, Ellsworth DL.

Ann Surg Oncol. 2008 Apr;15(4):1056-63. doi: 10.1245/s10434-008-9815-3. Epub 2008 Feb 2.

PMID:
18246400
27.

HYOU1/Orp150 expression in breast cancer.

Stojadinovic A, Hooke JA, Shriver CD, Nissan A, Kovatich AJ, Kao TC, Ponniah S, Peoples GE, Moroni M.

Med Sci Monit. 2007 Nov;13(11):BR231-239.

PMID:
17968289
28.

The Clinical Breast Care Project: an important resource in investigating environmental and genetic contributions to breast cancer in African American women.

Ellsworth RE, Zhu K, Bronfman L, Gutchell V, Hooke JA, Shriver CD.

Cell Tissue Bank. 2008 Jun;9(2):109-20. Epub 2007 Oct 11.

PMID:
17929197
29.

Genomic instability and the development of metastatic lymph node tumors.

Callaghan KA, Becker TE, Ellsworth DL, Hooke JA, Ellsworth RE, Shriver CD.

Ann Surg Oncol. 2007 Nov;14(11):3125-32. Epub 2007 Jul 25.

PMID:
17653592
30.

Correlation of levels and patterns of genomic instability with histological grading of DCIS.

Ellsworth RE, Ellsworth DL, Love B, Patney HL, Hoffman LR, Kane J, Hooke JA, Shriver CD.

Ann Surg Oncol. 2007 Nov;14(11):3070-7. Epub 2007 Jun 5.

PMID:
17549568
31.

Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors.

Ellsworth RE, Hooke JA, Love B, Kane JL, Patney HL, Ellsworth DL, Shriver CD.

Breast Cancer Res Treat. 2008 Jan;107(2):259-65. Epub 2007 Mar 10.

PMID:
17351743
32.

Co-occurrence analysis for discovery of novel breast cancer pathology patterns.

Maskery SM, Zhang Y, Jordan RM, Hu H, Hooke JA, Shriver CD, Liebman MN.

IEEE Trans Inf Technol Biomed. 2006 Jul;10(3):497-503.

PMID:
16871717
33.

Timing of critical genetic changes in human breast disease.

Ellsworth RE, Ellsworth DL, Deyarmin B, Hoffman LR, Love B, Hooke JA, Shriver CD.

Ann Surg Oncol. 2005 Dec;12(12):1054-60. Epub 2005 Oct 10.

PMID:
16228814
34.

Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes.

Ellsworth RE, Ellsworth DL, Neatrour DM, Deyarmin B, Lubert SM, Sarachine MJ, Brown P, Hooke JA, Shriver CD.

Mol Cancer Res. 2005 Feb;3(2):71-7.

35.

Genomic instability in histologically normal breast tissues: implications for carcinogenesis.

Ellsworth DL, Ellsworth RE, Liebman MN, Hooke JA, Shriver CD.

Lancet Oncol. 2004 Dec;5(12):753-8. Review.

PMID:
15581548
36.

Outer breast quadrants demonstrate increased levels of genomic instability.

Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, Hooke JA, Shriver CD.

Ann Surg Oncol. 2004 Sep;11(9):861-8. Epub 2004 Aug 16.

PMID:
15313734
37.

A 59-year-old woman with tuberculous meningitis masked by hepatic encephalopathy.

Carmichael MG, Thompson JC, Buttolph TB, Hooke JA.

Mil Med. 2003 Mar;168(3):266-9.

PMID:
12685697
38.

Ehrlichial meningitis with cerebrospinal fluid morulae.

Berry DS, Miller RS, Hooke JA, Massung RF, Bennett J, Ottolini MG.

Pediatr Infect Dis J. 1999 Jun;18(6):552-5. No abstract available.

PMID:
10391189

Supplemental Content

Loading ...
Support Center